[ad_1] Montreal, October 26, 2018 – Naglaa Shoukry, Ph.D., and her team have made significant progress in their research to limit the progression of liver disease. They have characterized the mechanisms of …
Read More »Interleukin IL-22, a new target to inhibit the progression of liver disease
